![]() |
Volumn 6, Issue 12, 2007, Pages 943-944
|
Bad bugs need more drugs
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
CEPHALOSPORIN;
NEW DRUG;
PLACEBO;
POLYPEPTIDE ANTIBIOTIC AGENT;
TETRACYCLINE DERIVATIVE;
TIGECYCLINE;
ACUTE OTITIS MEDIA;
ACUTE SINUSITIS;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL INFECTION;
BACTERIAL VIRULENCE;
CHRONIC BRONCHITIS;
CLINICAL STUDY;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG CLASSIFICATION;
DRUG COST;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
HOSPITAL INFECTION;
HUMAN;
LEGAL LIABILITY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NONHUMAN;
PATENT;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
UNITED STATES;
|
EID: 36749025072
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2477 Document Type: Article |
Times cited : (32)
|
References (0)
|